Skip to content

Optimal Balloon Catheter Placement During Sonohysterography

Pain Perception and Side Effects During Sonohysterography With Balloon Catheters: a Randomized Comparative Study of Cervical With Uterine Catheter Placement

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01936116
Enrollment
300
Registered
2013-09-05
Start date
2012-05-31
Completion date
2013-10-31
Last updated
2014-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

Sonohysterography, catheter placement, pain magnitude, vasovagal reaction

Brief summary

Saline infusion sonohysterography and other intrauterine investigations methods may cause uterine cramping, pain and vasovagal reactions. According to few of previous studies the position of catheter placement can affect the magnitude of pain and amount of saline required during the sonohysterography. The purpose of this double blind control trial study is to assess whether the location of the balloon catheter either the uterus or cervix during sonohysterography can affect the magnitude of pain and the rate of vasovagal reaction.

Detailed description

The proposal of study approved by the investigators institutional review boards and institution's ethical committee, and all participants will sign a written consent before enter to study. A total of 300 infertile women undergoing sonohysterography will be randomized to intrauterine or intracervical balloon catheter placement. The examination is scheduled in the early follicular phase of menstrual cycle, immediately after cessation of menstrual flow and before day 10. After preparation of patient, a 2 lumen 6-French flexible catheter is introduced into the cervical canal and balloon at the catheter tip is placed in the lower uterine segment or 1 cm into cervical canal and inflated with 1 mL of sterile saline solution. Under sonographic guidance, sterile normal saline solution (10-50 mL) is slowly introduced into the cavity until an adequate distention of the uterine cavity is obtained. Three-dimensional ultrasound scanned volumes are recorded. Patients are asked to assess their level of pain at the time of the balloon inflation and deflation using a 10-point visual analog pain scale. Patients are checked for the sign and symptoms of vasovagal reaction during and 30 minutes after procedure. Outcome measures will be assessed based on the intent-to-treat principle.

Interventions

DEVICEsonohysterography with inflated catheter in uterine cavity

during the procedure of sonohysterography balloon catheter is inflated in the uterine cavity

DEVICEsonohysterography with inflated catheter in cervical cavity

During the procedure of sonohysterography balloon catheter is inflated in the cervical canal

Sponsors

Royan Institute
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Infertile patients who will be referred to Royan institute for sonohysterography to evaluate the internal structure of uterine cavity (acquired & congenital abnormalities) are included in this prospective comparative study.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
perceived Painduring sonohysterographyinflation of the balloon & deflation of the balloon by a 10-point visual analog pain scale
Vasovagal reactionsDuring sonohysterographyEvaluation the vasovagal reactions (Hypotension, vomiting, syncope)in patients During procedure .
vasovagal reaction30 minutes after sonohysterographyEvaluation the vasovagal reactions (Hypotension, vomiting, syncope)in patients 30 minutes after procedure .

Secondary

MeasureTime frameDescription
Saline volumeduring sonohysterographyEvaluation the saline volume that is required for sonohisterography
time of procedureduring sonohysterographyEvaluation the total time that is needed for sonohysterography.

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026